Solta Medical to Report Third Quarter 2013 Results and Host Conference Call on November 11, 2013
HAYWARD, Calif., Oct. 28, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it will release its financial results for the third quarter ended September 30, 2013, after market close on Monday, November 11, 2013. The Company will also host a conference call and webcast on Monday, November 11, 2013, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results and current corporate developments. The dial-in number for the conference call is 877-941-0844 for domestic participants and 480-629-9835 for international participants.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The Company offers aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin tightening, as well as tools and accessories to optimize the latest liposuction techniques. Each brand is an established category leader, and together comprise of a comprehensive platform to address a range of aesthetic skin and body issues. Fraxel® delivers minimally-invasive clinical solutions to resurface aging and sun damaged skin. Clear + Brilliant® is a cost-effective, non-ablative laser treatment uniquely designed to improve skin tone and radiance. Isolaz® acne treatment combines vacuum and painless broadband light to address a wide variety of acne types. CLARO® is an FDA-cleared personal care acne device that uses heat and light to clear skin quickly and naturally. Thermage® is a non-invasive radiofrequency procedure that improves the appearance of wrinkles, which can result in smoother, more contoured skin. Liposonix® is a non-surgical single-treatment procedure that uses advanced high-intensity focused ultrasound technology to destroy targeted fat beneath the skin. VASERshape™ is a complementary non-invasive treatment that combines low frequency, non-focused ultrasound and lymphatic massage to temporarily reduce the appearance of cellulite and improve blood circulation with minimal pain or no downtime. The VASERlipo™ system uses ultrasound technology to selectively remove unwanted body fat. It includes VentX® technology that powers an aspiration system for quiet, efficient removal of fatty tissue and precision vented cannulas to maximize aspiration efficiency and speed. VASERsmooth™ is a unique body sculpting add-on tool for use with the VASERlipo system. PowerX® is a power-assisted liposuction system that uses a unique rotational motion which can be used with the VASERlipo system or to enhance traditional liposuction systems. The TouchView® system fits between the fingers and provides diagnostic imaging of subcutaneous structures during procedures. Both the VASERlipo system and traditional liposuction systems can utilize the Origins™ products, a complete line of custom liposuction infiltration, re-injection and aspiration cannulas and accessories. More than two and a half million procedures have been performed with Solta Medical's portfolio of products around the world.
For more information about Solta, call 1-877-782-2286 or log on to www.Solta.com.
SOURCE Solta Medical, Inc.